Rupali Bhave MD
Assistant Professor, Internal Medicine, University of Iowa Roy J. and Lucille A. Carver COM
Join to view full profile
S Hawthorne RdWinston-Salem, NC 27157
Phone+1 336-716-2011
Dr. Bhave is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Virginia Medical CenterResidency, Internal Medicine, 2006 - 2009
University of Arizona College of MedicineClass of 2006
Certifications & Licensure
NC State Medical License 2016 - 2027
IA State Medical License 2014 - 2018
MI State Medical License 2012 - 2016
IL State Medical License 2009 - 2014
VA State Medical License 2006 - 2009
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
Roles: Contact
- Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML Start of enrollment: 2018 Aug 16
Roles: Contact
Publications & Presentations
PubMed
- Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.Xiaoming Zhong, Kathryn G Roberts, Huimei Wei, Zhuoxin Sun, Lindsey E Montefiori
Blood. 2026-10-05 - 8 citationsECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera.John Mascarenhas, John Mascarenhas, Prithviraj Bose, Christopher Hillis, Abdulraheem Yacoub
Acta Haematologica. 2025-01-01 - 178 citationsBlinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, Elisabeth M Paietta, Kathryn G Roberts
The New England Journal of Medicine. 2024-07-25
Abstracts/Posters
- Evaluating the Utilization of All-Trans Retinoic Acid and Arsenic Trioxide during Consolidation Therapy for Patients Receiving Treatment for Acute Promyelocytic LeukemiaRupali Bhave, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly ActiveClinically Relevant AbstractRupali Bhave, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Therapeutic Manipulation of Cancer Cell Metabolism with the Mitochondrial Metabolism Inhibitor Cpi-613 in Addition to Chemotherapy Abrogates the Adverse Prognostic Eff...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with N...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Salman Fazal: Presenting Telomerase Inhibition in Myeloproliferative Neoplasms at the 2026 MPN Workshop of the CarolinasAugust 25th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: